维普中文期刊产品整合服务
15篇 您的检索式:作者名="Jan Rosing"
    题名 作者 年代 出处 被引量
1Characterization of New Members of the Group 3 Outer Membrane Protein Family of Brucella spp 显示文摘Imed Salhi Rose Anne Boigegrain Jan Machold 2003Infect Immun2003,71,8:1
2Snake venom activators of factor X:an review显示文摘Guido Tans Jans Rosing 2001Haemostasis2001,31,:1
3Snake venom activators of factor X an review显示文摘Guido Tans Jans Rosing 2001Haemostasis2001,31,36:1
4Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14 + Macrophages显示文摘Raja Atreya Michael Zimmer Brigitte Bartsch Maximilian J. Waldner Imke Atreya Helmut Neumann Kai Hildner Arthur Hoffman Ralf Kiesslich Andreas D. Rink Tilman T. Rau Stefan Rose–John Hermann Kessler Jan Schmidt Markus F. Neurath 2011Gastroenterology2011,,6:1
5Endoscopic endoluminal vacuum therapy is superior to other regimens in managing anastomotic leakage after esophagectomy: a comparative retrospective study显示文摘Bodo Schniewind Clemens Schafmayer Gesa Voehrs Jan Egberts Witigo Schoenfels Tobias Rose Roland Kurdow Alexander Arlt Mark Ellrichmann Christian Jürgensen Stefan Schreiber Thomas Becker Jochen Hampe 2013Surgical Endoscopy2013,,10:1
6Community Preferences for the Allocation of Solid Organs for Transplantation: A Systematic Review显示文摘Allison Tong Kirsten Howard Stephen Jan Alan Cass John Rose Steven Chadban Richard D. Allen Jonathan C. Craig 2010Transplantation2010,,7:1
7EAF foamy slag in stainless steel production : a new and extremely efficient technology, easy to handle and cost-efficient 显示文摘Reichel Jan Rose Lutz 2010Iron & Steel Technology2010,,2:1
8Should trade unions appreciate foreign direct investment 显示文摘Skaksen Mette Yde Srensen Jan Rose 2001Journal of Intemational Economics Volume: 55 Issue: 2 December2001,,:1
9Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation显示文摘Guido Tans Gerry A F Nicolaes Jan Rosing 1997Seminars in Hematology1997,34,:1
10Application of dried blood spots combined with high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry for simultaneous quantification of vincristine and actinomycin-D显示文摘Carola W. N. Damen Hilde Rosing Jan H. M. Schellens Jos H. Beijnen 2009Analytical and Bioanalytical Chemistry2009,,4:1
11Specialization, Outsourcing and Wages 显示文摘Jakob Roland Munch and Jan Rose Skaksen 2009Review World Economics2009,,145:1
12A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry显示文摘Carola W.N. Damen Hilde Rosing Matthijs M. Tibben Maria J. van Maanen Jurjen S. Lagas Alfred H. Schinkel Jan H.M. Schellens Jos H. Beijnen 2008Journal of Chromatography B2008,,1:1
13EAF-foamy slag in stainless steel production new extremely efficient technology easy to handle and cost-efflcient 显示文摘Reichel Jan Rose Lutz Kempken Jens 2008Archives of Metallurgy and Materials2008,53,2:1
14Snake venom activators of factor x:an overview显示文摘Guido Tans Jan Rosing 2001Haemostasis2001,31,3:1
15Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar显示文摘Many anticancer drugs have an impaired bioavailability and poor brain penetration because they are substrates to drug efflux pumps such as P-glycoprotein and Breast Cancer Resistance Protein.Elacridar is a strong inhibitor of these two drug efflux pumps and therefore has great potential to improve oral absorption and brain penetration of many anticancer drugs.Currently,a clinical formulation of elacridar is unavailable and therefore the pharmaceutical development of a drug product is highly warranted.This also necessitates the availability of an analytical method for its quality control.A reverse-phase high-performance liquid chromatographic method with ultraviolet detection was developed for the pharmaceutical quality control of products containing elacridar as the active pharmaceutical ingredient.The analytical method was validated for linearity,accuracy,precision,selectivity,carry-over,stability of stock and reference solutions,stability of the final extract,stability-indicating capability and impurity testing.We found that elacridar is unstable in aqueous solutions that are exposed to light because a hydroxylation product of elacridar is formed.Therefore,sample solutions with elacridar must be protected from light.Emilia Sawicki Michel J.Hillebrand Hilde Rosing Jan H.M.Schellens Bastiaan Nuijen Jos H.Beijnen 2016Journal of Pharmaceutical Analysis2016,6,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费